You are here

ALN-APP

AAIC: First Clinical Data from an RNAi Therapeutic for Alzheimer’s Continue to Impress

BioSpace

Tue, 07/18/23 - 11:55 am

Alzheimer's disease

clinical trials

Alnylam and Regeneron report updated positive Phase I results of Alzheimer’s drug

Clinical Trials Arena

Mon, 07/17/23 - 08:41 am

clinical trials

Alzheimer's disease

Alnylam’s early Alzheimer’s results encourage, but company discloses new hurdle

BioPharma Dive

Fri, 04/28/23 - 10:08 am

clinical trials

Alzheimer's disease